George McLendon is the Howard R. Hughes Provost and Professor of Chemistry at Rice University. He assumed the role of provost in 2010 after serving as Dean of Trinity College of Arts and Science at Duke University. Prior to his tenure at Duke, McLendon was the R.W. Moore Professor and chair of the Department of Chemistry at Princeton University. As provost, McLendon outlined a broad strategy called “The Rice Initiatives.” The initiatives encompass three main areas of focus: bioscience and health, energy and the environment, and international strategy. He is also pursuing an international strategy for expanding Rice’s image abroad. Previously, McLendon’s research is focused on inorganic and physical biochemistry.
He has published over 200 peer reviewed papers and received national research awards, including the American Chemistry Society Pure Chemistry Award, the Eli Lilly Award in Ecochemistry, Sloan Dreyfus Award, and Guggenheim Fellowships. His publications range from solar nanotechnology to cell death pathways. His most recent research has direct implications for the diagnosis and treatment of cancer and other diseases. He has been involved in launching several biotech startups, including Tetralogic Pharmaceuticals which went public in December 2013 (Nasdaq: TLOG).
Dr. McLendon holds a doctorate from Texas A&M University and a bachelor’s degree from the University of Texas at El Paso.
